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West Nile virus (WNV) is a 
mosquito-borne viral pathogen 
that was introduced into the 
United States in 1999. Within 
four years following its initial 
detection in New York, WNV 
was found in states from the East 
to the West coasts as well as in 
Mexico and Canada. 
WNV, an arbovirus, is 
maintained in birds; its presence 
in Georgia was first confirmed in July 2001 when an 
American crow from Lowndes County tested positive for 
the virus. The virus occasionally infects humans who are 
bitten by mosquitoes that have been feeding on birds.  Most 
people (approximately 80%) infected with WNV do not 
develop symptoms. About one in five infected people 
experiences a relatively mild illness, often termed “West 
Nile Fever”, characterized by fever, headache, muscle 
weakness or myalgia, arthralgia, and sometimes rash. Less 
than one percent of persons infected with WNV develop 
neurologic illness (“West Nile Neurologic Disease” or 
WNND) in the form of meningitis, encephalitis, or possibly 
acute flaccid paralysis. Approximately three to fifteen 
percent of WNND cases are fatal. An increased risk of 
WNND is associated with increasing age and the presence 
of underlying medical conditions.  Recently, in Georgia, 
there have been human WNV cases each year, ranging from 
a low of 6 cases in 2001 to a high of 117 cases in 2012.   
Integrated management practices for mosquito control 
include education, surveillance, source reduction, 
larviciding, and adulticiding as the means to reduce 
mosquito populations below a threshold amount. Reminding 
the public at the start of mosquito season that wearing 
repellent reduces the risk of WNV is essential, as is 
reminding people of their role in reducing mosquito 
populations by eliminating mosquito-breeding areas in their 
yards and in their neighborhoods. This message should 
include “tip and toss”; at least once a week correctly dispose 
of debris that can contain water; dump out anything that can 
hold water.  This includes wading pools, pots, buckets, 
saucers under plants, toys, leaves, tarps, and plastic bags.  
Applying a larvicide to catch basins and other locations 
starting in March or April will help reduce populations of 
Culex spp mosquitoes, the principal vectors of WNV. Two 
larvicidal products are available to consumers, Mosquito 
Dunks® (Bacillus thuringiensis serotype israelenis) and 
Mosquito Torpedoes® (methoprene).  It is necessary to read 
and follow label directions when using either of these 
products.   
Application of larvicides and education by public health 
officials in response to positive birds or increased numbers 
of vectors has the effect of minimizing the risk of human 
disease in areas where the virus is actively circulating. 
When adult mosquito populations begin to rise, adulticiding, 
either area-wide or a more localized barrier spray, should be 
considered to reduce mosquito populations.  If a municipal 
mosquito control program does not exist in their area, 
residents may choose to contract with a commercial 
mosquito control company or to apply a barrier spray in 
their own yards.  Additional information concerning 
mosquito control can be found on the Georgia Mosquito 
Control website at www.GAmosquito.org.  
Information is the key to reducing the risk of WNV 
transmission. Data obtained from mosquito surveillance 
efforts leads to responsible and informed decisions about 
mosquito control, as well as public education about 
elimination of mosquito breeding habitats and prevention of 
mosquito bites.  For this disease, communication between 
agencies and the public is an essential part of the risk 
reduction effort.   
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